Friday, September 11, 2026
RSS

Markets & Money

Technical Analysis: US Stocks at a Crossroads Amid Rising Oil Prices and Inflation Concerns

As rising oil prices and inflation loom, US stocks face critical support levels that could shape market sentiment.

By Marcus Rivera • September 10, 2026
Pharmaceutical

Merck (MRK) and Moderna (MRNA) Achieve Breakthrough in mRNA Cancer Vaccine Development: What it Means for Investors

Merck and Moderna's Phase 3 trial results for their mRNA cancer vaccine could reshape oncology and investor sentiment.

Sarah Chen • Sep 10
Pharmaceutical

Revolution Medicines (RVMD) Gains Momentum Post-FDA Approval: What Investors Should Know

Revolution Medicines is gaining traction following FDA approval for Rasonque, signaling potential market shifts.

James McAllister • Sep 10
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Pharmaceutical

Revolution Medicines Gains Traction with FDA Approval of Rasonque and Morgan Stanley Overweight Rating

Revolution Medicines sees renewed investor interest as Rasonque gains FDA approval and Morgan Stanley issues an Overweig…

Marcus Rivera • Sep 10, 2026
Pharmaceutical

Genentech's Enspryng Gets FDA Priority Review for MOGAD: What the Accelerated Timeline Means

The FDA's Priority Review of Enspryng for rare disease MOGAD could compress Genentech's approval timeline and unlock a n…

Sarah Chen • Sep 10, 2026
Pharmaceutical

Axogen Expands Nerve Repair Portfolio with $200M BioCircuit Acquisition

Axogen's $200M acquisition of BioCircuit Technologies marks a significant expansion in the nerve repair market.

James McAllister • Sep 10, 2026
Energy

Oil Prices Surge as US-Iran Tensions Escalate: What This Means for North American Markets

Brent crude prices have crossed $100 per barrel amid rising US-Iran tensions, impacting inflation and investor strategie…

Marcus Rivera • Sep 9, 2026
Tech

Analog Devices Expands AI Capabilities with $1.35 Billion Acquisition of Alif Semiconductor

Analog Devices' $1.35 billion acquisition of Alif Semiconductor could reshape the edge AI chip market.

Sarah Chen • Sep 9, 2026
Pharmaceutical

Roivant Sciences Gains Traction as Mosliciguat Progresses to Phase 3 Trials

Roivant Sciences sees increased investor confidence as it advances mosliciguat to Phase 3 trials, boosted by TD Cowen's …

James McAllister • Sep 9, 2026
Energy

Brent Crude Hits $100: Implications for US Equity Markets Amid Geopolitical Tensions

Brent crude oil prices soar past $100, raising concerns about US equity markets and consumer behavior amid rising geopol…

Marcus Rivera • Sep 9, 2026
Tech

Analog Devices Expands Semiconductor Portfolio with $1.35B Acquisition of Alif Semiconductor

Analog Devices' $1.35 billion acquisition of Alif Semiconductor signals a strategic push into the growing AI and edge co…

James McAllister • Sep 9, 2026
Tech

Apple's Acquisition of Sonera Magnetics: A Bold Move into Neurotechnology

Apple's acquisition of Sonera Magnetics signals a strategic leap into health-tech, reshaping its competitive landscape a…

Marcus Rivera • Sep 8, 2026